AIM ImmunoTech Inc. earnings per share and revenue
On 17 nov 2025, AIM reported earnings of -1.57 USD per share (EPS) for Q3 25, missing the estimate of -0.98 USD, resulting in a -59.42% surprise. Revenue reached 26.00 mil, compared to an expected --, with a 0.00% difference. The market reacted with a -7.64% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of -0.97 USD, with revenue projected to reach -- USD, implying an reducir of -38.22% EPS, and reducir of -100.00% in Revenue from the last quarter.
Preguntas frecuentes
What were AIM ImmunoTech Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, AIM ImmunoTech Inc. reported EPS of -$1.57, missing estimates by -59.42%, and revenue of $26.00K, 0% as expectations.
How did the market react to AIM ImmunoTech Inc.'s Q3 2025 earnings?
The stock price moved down -7.64%, changed from $1.44 before the earnings release to $1.33 the day after.
When is AIM ImmunoTech Inc. expected to report next?
The next earning report is scheduled for 30 mar 2026.
What are the forecasts for AIM ImmunoTech Inc.'s next earnings report?
Based on 3
analistas, AIM ImmunoTech Inc. is expected to report EPS of -$0.97 and revenue of -- for Q4 2025.